相关实验视频

Updated: Jan 8, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

对复发性高度质瘤的治疗策略和创新

Jan Drappatz¹, Megan Mantica²

¹Hillman Cancer Center, Departments of Neurology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. drappatzj@upmc.edu.

Journal of neuro-oncology

|December 11, 2025

概括

复发性高度质瘤 (HGG) 治疗正在发展. 针对性疗法,免疫疗法和药物输送方面的进步为患者提供了渐进的进步,强调临床试验和分子分析.

科学领域:

神经瘤学神经瘤学
医学瘤学医学瘤学
翻译研究是翻译研究.

背景情况:

复发性高度质瘤 (HGG),包括质母细胞瘤,具有显著的治疗挑战,后进展生存时间有限.
虽然IDH突变瘤可能提供更好的预后,但HGG仍然在很大程度上具有致命性.
不断发展的临床试验数据和最近的监管批准正在重塑治疗范式.

研究的目的:

审查目前和新兴的系统性治疗策略,以治疗复发性高度质瘤.
总结各种治疗方式的证据,包括基剂,抗血管原剂,向疗法和免疫疗法.
提出以患者为中心的方法,整合临床试验,生物标志物指导治疗和支持性护理.

主要方法:

对基化剂,抗血管生成疗法,向药物和免疫疗法的综合文献综述.
关于DNA损伤反应 (DDR) 抑制剂,细胞疗法和血脑屏障 (BBB) 调制技术的概述.
讨论地方区域交付系统和适应性临床试验设计.

主要成果:

已经确立的治疗方法,如隆慕斯丁,temozolomide重试,和bevacizumab提供适度的好处.
向药物在特定的分子子集 (例如,BRAF V600E,NTRK) 中表现出有效性.
包括DDR抑制剂,免疫疗法组合和先进的药物输送平台在内的新兴策略显示出有前途,首个FDA批准的治疗方法是复发时治疗H3K27M突变扩散中线质瘤.

结论:

尽管整体结果不佳,但在多种治疗途径上正在取得渐进的进展.
专注于临床试验招生,分子分析和症状管理的以患者为中心的策略至关重要.
未来的方向涉及合理的组合方法,以改善选择的HGG患者的结果.

关键词:

生物标志物生物标志物质母细胞瘤 (glioblastoma) 是一个 IDH IDH 是一个字母.免疫治疗是一种免疫疗法.在MGMT中,我们可以看到MGMT.

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.